Recent advances in the fourth pillar of cancer treatment—immunotherapy—suggest that the immune system may be our best tool to cure more cancers. Join us to learn more about how the move to an immunotherapeutic approach to treat canine cancer can make a difference for your patients and their families. Dr. Wayne Carter, CEO of TVAX Biomedical will discuss the science behind using killer T cells to treat cancer, and Dr. Noe Reyes, Chief Medical Officer of ELIAS Animal Health will review results of a clinical study in canine osteosarcoma and discuss the treatment protocol. Dr. Julie Bulman-Fleming and Dr. Brooke Fowler will discuss their experiences with the protocol, how to practically implement it, and why it is critical to refer patients before amputation.
• Learn how this pioneering approach to canine cancer treatment harnesses the power of the immune system
• Understand how this immunotherapeutic approach can differentiate your practice, whether you are a specialty hospital or a general practice clinic
• Find out how you can offer an innovative treatment option to pet owners looking for a new way to care for a valued member of their family